Global Blood Therapeutics (GBT) Reports Q2 LPS of $0.58
Tweet
Share
E-mailGet Alerts GBT Hot Sheet
Price: $68.49 --0%
Financial Fact:
Earnings per share - diluted: 0.12
Today's EPS Names:
HMR, RZLV, ZEPP, More
Financial Fact:
Earnings per share - diluted: 0.12
Today's EPS Names:
HMR, RZLV, ZEPP, More
Join SI Premium – FREE
Global Blood Therapeutics (NASDAQ: GBT) reported Q2 EPS of ($0.58), versus ($4.84) reported last year.
Cash and cash equivalents totaled $231.9 million at June 30, 2016 compared with $148.5 million at December 31, 2015.
For earnings history and earnings-related data on Global Blood Therapeutics (GBT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- PG&E downgraded by Wells Fargo, BMO as California wildfire reform falls short
- UBS Downgrades H.U. Group Holdings Inc (4544:JP) to Neutral
- RBC Capital Downgrades GQG Partners Inc (GQG:AU) to Sector Perform
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
